PRESENCE OF ANTIBODIES TO ADALIMUMAB AND INFLIXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN CLINICAL REMISSION

被引：0
|
作者：
Eng, G. [1 ,2 ]
Fana, V. [3 ]
Omerovic, E. [4 ]
Hojsgaard, P. [5 ]
Lindegaard, H. M. [6 ]
Jensen, E. K. [7 ]
Bouchelouche, P. N. [1 ]
机构：
[1] Copenhagen Univ Hosp Koge, Koge, Region Zealand, Denmark
[2] Copenhagen Univ Hosp Frederiksberg & Bispebjerg, Dept Rheumatol, Parker Inst, Copenhagen, Denmark
[3] Copenhagen Univ Hosp, Glostrup, Denmark
[4] Copenhagen Univ Hosp Frederiksberg & Bispebjerg, Copenhagen, Denmark
[5] Copenhagen Univ Hosp, Gentofte, Denmark
[6] Odense Univ Hosp, DK-5000 Odense, Denmark
[7] Copenhagen Univ Hosp Holbaek, Holbaek, Denmark
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：230 / 230
页数：1
相关论文
共 50 条
  • [1] Antibodies to Infliximab and Adalimumab in Patients with Rheumatoid Arthritis in Clinical Remission: A Cross-Sectional Study
    Eng, Grith P.
    Bendtzen, Klaus
    Bliddal, Henning
    Stoltenberg, Michael
    Szkudlarek, Marcin
    Fana, Viktoria
    Lindegaard, Hanne M.
    Omerovic, Emina
    Hojgaard, Pil
    Jensen, Elmo K.
    Bouchelouche, Pierre N.
    ARTHRITIS, 2015,
  • [2] Discontinuation of infliximab in rheumatoid arthritis patients in clinical remission
    Nawata, Masao
    Saito, Kazuyoshi
    Nakayamada, Shingo
    Tanaka, Yoshiya
    MODERN RHEUMATOLOGY, 2008, 18 (05) : 460 - 464
  • [3] Clinical Response in Rheumatoid Arthritis Patients with Anti-Infliximab Antibodies
    Opris, Daniela
    Mazilu, Diana
    Ionescu, Ruxandra
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : S40 - S41
  • [4] ANTIBODIES TO ETANERCEPT AND ADALIMUMAB IN RHEUMATOID ARTHRITIS INADEQUATE RESPONDERS AND CLINICAL OUTCOMES AFTER AN ACTIVE SWITCH TO INFLIXIMAB
    Pool, C.
    Shankar, G.
    Schantz, A.
    Gunn, G.
    Bolce, R.
    Leirisalo-Repo, M.
    Wang, J.
    Goldman, J.
    DeHoratius, R.
    Fleischmann, R.
    Decktor, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 224 - 225
  • [5] Antibodies to Etanercept and Adalimumab in Rheumatoid Arthritis Inadequate Responders and Clinical Outcomes After an Active Switch to Infliximab
    Pool, Chad
    Shankar, Gopi
    Schantz, Allen
    Gunn, George
    Bolce, Rebecca
    Leirisalo-Repo, Marjatta
    Wang, Jim
    Goldman, John A.
    DeHoratius, Raphael J.
    Fleischmann, Roy M.
    Decktor, Dennis
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S551 - S551
  • [6] Presence of anti-nuclear antibodies is a risk factor for the appearance of anti-drug antibodies during infliximab or adalimumab therapy in patients with rheumatoid arthritis
    Mori, Ayano
    Saito, Toshiharu
    Takahashi, Miho
    Shibata, Miho
    Tsuji, Goh
    Hatachi, Saori
    Takahashi, Soshi
    Kumagai, Shunichi
    PLOS ONE, 2020, 15 (12):
  • [7] Demographics and clinical characteristics associated with sustained remission and continuation of sustained remission in patients with rheumatoid arthritis treated with adalimumab
    Kimura, Noriko
    Suzuki, Katsuya
    Takeuchi, Tsutomu
    INFLAMMATION AND REGENERATION, 2019, 39 (1)
  • [8] Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis
    Radstake, T. R. D. J.
    Svenson, M.
    Eijsbouts, A. M.
    van den Hoogen, F. H. J.
    Enevold, C.
    van Riel, P. L. C. M.
    Bendtzen, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (11) : 1739 - 1745
  • [9] Demographics and clinical characteristics associated with sustained remission and continuation of sustained remission in patients with rheumatoid arthritis treated with adalimumab
    Noriko Kimura
    Katsuya Suzuki
    Tsutomu Takeuchi
    Inflammation and Regeneration, 39
  • [10] Infliximab, Etanercept, and Adalimumab switching in patients with rheumatoid arthritis in the CORRONA database
    Dabbous, O.
    Kremer, J.
    Rambharose, J.
    El Taha, M.
    Reed, G.
    Tang, B.
    Thomson, H.
    Domdey, A.
    Rahman, M.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2008, 37 : 42 - 42
12345